Hem › Myelodysplastiska syndrom › Alabama
Kliniska studier för Myelodysplastiska syndrom i Alabama
10 studier för Myelodysplastiska syndrom söker deltagare vid platser i Alabama.
Städer i Alabama
Officiell studietext (engelska)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Alabama at Birmingham Cancer Center, Birmingham
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05564390The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
RekryterarFas 1/2
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 30 apr. 2026 · NCT05297734UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- University of Alabama at Birmingham, Birmingham
RekryterarFas 1
4 Weeks – 75 Years · Alla kön · Uppdaterad 13 apr. 2026 · NCT06047886Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- University of Alabama at Birmingham, Birmingham
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 4 mars 2026 · NCT07044544CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- University of Alabama O'Neal Cancer Center, Birmingham
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 16 jan. 2026 · NCT05143996SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 8 okt. 2025 · NCT06265584Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
RekryterarFas 2
Ålder 18 till 60 · Alla kön · Uppdaterad 8 okt. 2025 · NCT06315309HPC Offered for PRESERVE Expansion
- University of Alabama, Birmingham, Birmingham
RekryterarObservationsstudie
Ålder 12 till 80 · Alla kön · Uppdaterad 28 aug. 2025 · NCT07145411Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.